Cancer Clinical Trial - Biomarkers of Immune-Related Toxicity

Status Recruiting

Clinical Trial Summary

This is a single-center, correlative pilot study evaluating potential biomarkers predictive of immune-related adverse events associated with immune checkpoint inhibitor therapy.

Clinical Trial Description

This is a single-center, correlative pilot study evaluating potential biomarkers predictive of immune-related adverse events associated with immune checkpoint inhibitor therapy. The study includes a control population of patients receiving standard chemotherapy as a comparator. Patients will undergo blood draws at 4 time-points while on standard of care treatment. There are no study-related medications or interventions beyond blood sampling. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03409016
Study type	Observational
Source	University of Colorado, Denver
Contact	Mark Morrow
Phone	720-848-0665
Email	mark.morrow@ucdenver.edu
Status	Recruiting
Phase
Start date	February 26, 2018
Completion date	May 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01285037` - A Study of LY2801653 in Advanced Cancer	Phase 1
Completed	`NCT00680992` - Study of Denosumab in Subjects With Giant Cell Tumor of Bone	Phase 2
Terminated	`NCT02866851` - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy	N/A
Completed	`NCT00340522` - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting	`NCT03109041` - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source	Phase 1
Active, not recruiting	`NCT03167372` - Pilot Comparison of N-of-1 Trials of Light Therapy	N/A
Terminated	`NCT01441115` - ECI301 and Radiation for Advanced or Metastatic Cancer	Phase 1
Completed	`NCT01077414` - Phenomenological Study of Psycho-Socio-Spiritual Healing in the Context of Chronic or Life-Threatening Illness
Completed	`NCT01340846` - A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors	Phase 1
Recruiting	`NCT02565004` - Clinical and Laboratory Analysis of Familial Cancer
Active, not recruiting	`NCT02502396` - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center	N/A
Not yet recruiting	`NCT03662061` - Assessment of a Multidisciplinary Team Meeting (RCP) in Geriatric Oncology
Recruiting	`NCT03247309` - TCR-engineered T Cells in Solid Tumors With Emphasis on NSCLC and HNSCC (ACTengine)	Phase 1
Completed	`NCT03272880` - Utilizing the Arts to Improve Health, Resilience, and Well-Being Among Cancer Patients and Their Caregivers	N/A
Active, not recruiting	`NCT00587886` - Estrogen, Diet, Genetics and Endometrial Cancer
Recruiting	`NCT03548077` - POWERPLAY: Promoting Men's Health at Work	N/A
Completed	`NCT03503838` - A Pilot Study of Online Yoga for MPN Patients	N/A
Completed	`NCT00984035` - Investigation of Cisplatin-Related Kidney Toxicity
Completed	`NCT01447186` - Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men	N/A
Not yet recruiting	`NCT03257969` - Impact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients With Risk Factors	N/A